Benedetta Pellegrino

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Polycystic Ovary Syndrome

Breast Cancer Risk

Top Venues

Cancer research

The journal of pathology. Clinical research

Molecular diagnosis & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Annalisa Petrelli, Sabrina Rizzolio, Filippo Pietrantonio, Sara Erika Bellomo, Matteo Benelli, Loris De Cecco, Dario Romagnoli, Enrico Berrino, Claudia Orrù, Salvatore Ribisi, Daniel Moya-Rull, Cristina Migliore, Daniela Conticelli, Irene M Maina, Elisabetta Puliga, Violeta Serra, Benedetta Pellegrino, Alba Llop-Guevara, Antonino Musolino, Salvatore Siena, Andrea Sartore-Bianchi, Michele Prisciandaro, Federica Morano, Maria Antista, Uberto Fumagalli Romario, Giovanni De Manzoni, Maurizio Degiuli, Gian Luca Baiocchi, Marco F Amisano, Alessandro Ferrero, Caterina Marchio, Simona Corso, Silvia Giordano
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors. Cancer research 83 (10) (2023)
Annalisa Petrelli, Sabrina Rizzolio, Filippo Pietrantonio, Sara Erika Bellomo, Matteo Benelli, Loris De Cecco, Dario Romagnoli, Enrico Berrino, Claudia Orrù, Salvatore Ribisi, Daniel Moya-Rull, Cristina Migliore, Daniela Conticelli, Irene M Maina, Elisabetta Puliga, Violeta Serra, Benedetta Pellegrino, Alba Llop-Guevara, Antonino Musolino, Salvatore Siena, Andrea Sartore-Bianchi, Michele Prisciandaro, Federica Morano, Maria Antista, Uberto Fumagalli Romario, Giovanni De Manzoni, Maurizio Degiuli, Gian Luca Baiocchi, Marco F Amisano, Alessandro Ferrero, Caterina Marchio, Simona Corso, Silvia Giordano
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors. Cancer research 83 (10) (2023)
Annalisa Petrelli, Sabrina Rizzolio, Filippo Pietrantonio, Sara Erika Bellomo, Matteo Benelli, Loris De Cecco, Dario Romagnoli, Enrico Berrino, Claudia Orrù, Salvatore Ribisi, Daniel Moya-Rull, Cristina Migliore, Daniela Conticelli, Irene M Maina, Elisabetta Puliga, Violeta Serra, Benedetta Pellegrino, Alba Llop-Guevara, Antonino Musolino, Salvatore Siena, Andrea Sartore-Bianchi, Michele Prisciandaro, Federica Morano, Maria Antista, Uberto Fumagalli Romario, Giovanni De Manzoni, Maurizio Degiuli, Gian Luca Baiocchi, Marco F Amisano, Alessandro Ferrero, Caterina Marchio, Simona Corso, Silvia Giordano
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors. Cancer research (2023)
Claire J H Kramer, Alba Llop-Guevara, Elisa Yaniz-Galende, Benedetta Pellegrino, Natalja T Ter Haar, Andrea Herencia-Ropero, Nicoletta Campanini, Antonino Musolino, Tjalling Bosse, Alexandra Leary, Violeta Serra, Maaike P G Vreeswijk
RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test. The journal of pathology. Clinical research (2023)
Benedetta Pellegrino, Andrea Herencia-Ropero, Alba Llop-Guevara, Flaminia Pedretti, Alejandro Moles-Fernández, Cristina Viaplana, Guillermo Villacampa, Marta Guzmán, Olga Rodríguez, Judit Grueso, Jose Jiménez, Enrique J Arenas, Andrea Degasperi, Joao M L Dias, Josep V Forment, Lenka Oplustil O'Connor, Olivier Déas, Stefano Cairo, Yinghui Zhou, Antonino Musolino, Carlos Caldas, Serena Nik-Zainal, Robert B Clarke, Paolo G Nuciforo, Orland Díez, Xavier Serres-Créixams, Vicente Peg, Martín Espinosa-Bravo, Teresa Macarulla, Ana Oaknin, Joaquin Mateo, Joaquín Arribas, Rodrigo Dienstmann, Meritxell Bellet-Ezquerra, Mafalda Oliveira, Cristina Saura, Sara Gutiérrez-Enríquez, Judith Balmaña, Violeta Serra
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification. Cancer research 82 (8) (2022)
Benedetta Pellegrino, Zuzana Hlavata, Cristina Migali, Pushpamali De Silva, Marco Aiello, Karen Willard-Gallo, Antonino Musolino, Cinzia Solinas
Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression. Molecular diagnosis & therapy 25 (4) (2021)
Benedetta Pellegrino, Joaquin Mateo, Violeta Serra, Judith Balmaña
Controversies in oncology: are genomic tests quantifying homologous recombination repair deficiency (HRD) useful for treatment decision making? ESMO open 4 (2) (2019)